StockCentral :: Community

Join in on the discussion with other like-minded investors in our community forums. Learn about the fundamental investing methodology and participate in educational workshops in the Investing forums, stay up-to-date on StockCentral news and make suggestions to the StockCentral team in Central Square, and discuss your favorite stock or recent market news in our A-Z ticker-based forums.

Subject: Teva Pharmaceuticals
Prev Topic Next Topic
Note: You must be a StockCentral subscriber and logged in to post messages.
Author Messages

jncraig


09/20/2006 9:35 PM  
Teva Pharmaceuticals, ticker symbol TEVA on the NASDAQ, is a large company based on FY2005 revenues of $5.25 billion. It is in the Pharmaceuticals industry. TEVA is also covered by the Investor Advisory Service as of the August 2006 issue, and is rated 3 for quality (on a scale of 1 to 5, with 1 being highest).

Rajiv Roy


10/14/2006 11:39 AM  
Here is an analysis of TEVA using the Stockcentral .SSG file

http://www.stockfundas.com/default.aspx?cmd=cmdRcvTckAnl&frmUsrId=3&tckId=7824

I used 17% for EPS growth. Mean estimate was 18% according to Reuters.

They are benefiting from the trend towards generics.

Rajiv
www.stockfundas.com

Rajiv
www.stockfundas.com

Irving Roth


01/09/2007 10:19 AM  
Zacks is projecting a negative EPS growth rate for 2007. This is after TEVA indicated a share buy back program which, by definition should make EPS move upward. That being the case, why would Zacks predict a negative growth rate?

Ray Marchand


03/22/2007 9:03 AM  

SEC filing shows a significently lower 2006 EPS than does the SSG.

Pre tax profit took a nosedive in 2006.

Something does not add up

Ray Marchand

 


Laura Scott
Florida


03/24/2007 9:25 AM  
Then why does the stock price keep going up? 

Kenneth Peters
Merritt Island
www.naicspace.org

04/25/2007 10:16 PM  
Good question, Laura.
You may also want to peruse the attached plots of TEVA.  In the first one you will note the decrease of earnings, tangible book value, and cash flow.
The second from an earlier time shows the S&P Core Earnings for 2001 through 2004.  For whatever reason S&P not longer reports these important S&P Core earnings for TEVA.  I have no idea why.
Data for the plots is from the S&P Reports.
Irv mentioned that Zacks predicted a dip in 2007 earnings.  So does Value Line.

Attachment: TEVAplot.pdf


Ken

Lynn Brown


06/20/2007 9:30 PM  

The SSG I did on Toolkit 5 using Stock Central data showed PTP up and down on the front and then had "down" in Section 2.  However, the SSG on Take Stock (program on my computer, which seems to be using S&P, has almost railroad tracks and up in Section 2 A.  It also has 8.9 rating.  This is contrast to Take Stock on Stock Central which has a 3 rating and don't buy.  It is frustrating when all of the data is so different.  Any explanations why and which should we use? 

Lynn

Note: You must be a StockCentral subscriber and logged in to post messages.
Forums > Stocks with tickers beginning R-Z > TEVA > Teva Pharmaceuticals



ActiveForums 3.7
 



Register today for a free 45-day trial!

 

Investment Club Tools Investor Advisory Service Historical data by Historical prices by Instant Stock Analysis by About ICLUBcentral Inc.
myiclubBadge.gif IASBadge.gif HemscottBadge.gif CSIBadge.gif TakeStockBadge.gif ICLUBcentralBadge.gif